The Radcliffe Department of Medicine (RDM), University of Oxford, is a large multi-disciplinary department with research interests that span the translational spectrum, from basic biological research through to clinical application.
The department has internationally renowned programmes in a broad range of sciences related to medicine, ranging from cardiovascular, diabetes, endocrinology, and stroke research, to molecular medicine, immunology, haematology and pathology, including programmes in stem cell & regenerative medicine.
The Radcliffe Department of Medicine, Oxford, is led by Prof Hugh Watkins. Read more
The Radcliffe Department of Medicine is fully committed to implementing the Athena SWAN initiative and supporting the careers of its students and staff. RDM currently holds a Silver award. Read more
A new paper, by Dr Rupert McShane from RDM, published in The Lancet Psychiatry, sets out principles for responsibly testing innovative treatments for severe depression, based on treating more than 100 patients with approximately 1,000 infusions of ketamine over six years in Oxford.
An exciting new chapter in NHS medical research in Oxford began at the start of April, with the £113.7m renewal of the NIHR Oxford Biomedical Research Centre (BRC). The BRC is a partnership between Oxford University Hospitals NHS Foundation Trust and the University of Oxford to fund medical ...
We are delighted to announce that researchers in RDM have been selected to take part in the Royal Society Summer Science Exhibition – a prestigious science festival that showcases the best of UK research. Our stand – DNA Origami: How do you fold a genome? – will use a mixture of virtual reality ...